Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.

Acta neuropathologica - 1 Dec 2017

Lopez Giselle Y, Oberheim Bush Nancy Ann, Phillips Joanna J, Bouffard John-Paul, Moshel Yaron A, Jaeckle Kurt, Kleinschmidt-DeMasters B K, Rosenblum Marc K, Perry Arie, Solomon David A

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Aged
Brain
Brain Neoplasms
Fatal Outcome
Gene Expression
Glioma
Histones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 29063183
DOI: 10.1007/s00401-017-1780-0
PMCID: PMC6078201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.PMID 29063183Read ↗

Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.Semantic proximity Read ↗

Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic Understanding.Semantic proximity Read ↗

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.Semantic proximity Read ↗

Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior.Semantic proximity Read ↗

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline GliomaSemantic proximity Read ↗

H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.Semantic proximity Read ↗

H3 K27M-mutant diffuse midline gliomas in different anatomical locations.Semantic proximity Read ↗

Molecular and clinical characterization of H3 K27M-mutant "non-midline" glioblastoma: A case report and literature review.Semantic proximity Read ↗

Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.Semantic proximity Read ↗

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Semantic proximity Read ↗

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.Semantic proximity Read ↗

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.